Clinical Trials

Squamous Cell Carcinoma of Head and Neck

NCT04398524 2024-01-16

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

65 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03669718 2023-12-29

A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

194 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06170697 2023-12-20

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

46 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06107114 2023-11-22

CZCNRHNSCC

52 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06142318 2023-11-21

Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma

66 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02624128 2023-11-13

V-CHANCE

39 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT06130007 2023-11-13

B2023-153

48 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03088059 2023-11-03

UPSTREAM

340 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06081582 2023-10-13

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

33 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06023875 2023-09-05

NCCCNRHNSCC

Squamous Cell Carcinoma of Head and Neck

NCT04297995 2023-08-08

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

131 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05965154 2023-07-28

Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

22 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05803915 2023-04-07

Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy

57 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT01590355 2023-03-08

ORATOR

68 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05749042 2023-03-01

A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

70 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05721443 2023-02-10

Cetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCC

26 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05611463 2022-11-10

CHANCE

25 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05351762 2022-07-05

Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC

55 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02748707 2022-04-28

ERLO-XIB

64 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT05294900 2022-03-25

NEOS

79 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05075122 2022-03-09

FOCUS

75 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

43 enrolled

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

NCT05189184 2022-01-12

HNSCC

Squamous Cell Carcinoma of Head and Neck

NCT05136768 2021-11-29

LM-HNSCC

50 enrolled

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

NCT04367909 2021-11-08

A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma

68 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04650633 2021-10-29

SHR-1701 in Patients With Recurrent/Metastatic Scchn

130 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05024019 2021-08-27

Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery

95 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04999800 2021-08-11

Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1

20 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03450967 2021-08-10

Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC

31 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04882462 2021-05-12

Carpp-1

100 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04861467 2021-04-27

Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

155 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04523883 2021-04-15

IMPORT

316 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT04440917 2021-02-02

IMplus

32 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03874741 2020-05-27

SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma

25 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT04399785 2020-05-22

Phase II Study for Combination of Camrelizumab and SBRT in the First-line Treatment for R/M HNSCC

34 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04296747 2020-03-05

Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer

100 enrolled

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms

NCT04222543 2020-01-10

PIVOT

20 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04146181 2019-12-12

Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma

103 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04164238 2019-11-15

Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients

90 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03830385 2019-07-16

Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck

51 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02216916 2019-03-18

Phase II Trial of HM781-36B in Patients With Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of or Unfit for Platinum-containing Therapy

49 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03843671 2019-02-18

Hyperbaric Radiation Sensitization of Head and Neck Cancers

400 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03121313 2019-02-12

Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+

68 enrolled

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT03744208 2018-11-16

SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03096184 2018-10-09

A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers

38 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03424291 2018-02-06

A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

60 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02639858 2017-05-01

Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC

31 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02753140 2016-04-27

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

60 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02739204 2016-04-15

Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma

270 enrolled